- ►prsjournal.com I Bahar, I Kaiserman, P McAllum, D Rootman, … - Cornea, 2008 - journals.lww.com Results: No significant ocular or systemic adverse events were ob- served during
3.5 6 1.1 months of follow-up. Seven patients showed partial regression of
vessels. The extent decreased from 6.0 6 1.2 (SD) clock hours before the ... Cited by 48 - Related articles - BL Direct - All 7 versions
F Bock, Y König, F Kruse, M Baier, C … - Graefe's Archive for Clinical and Experimental …, 2008 - Springer Abstract Background To analyze the ability of bevacizumab (Avastin) eye drops to
inhibit corneal neovascularization. Design: interventional case series involving
five patients (age: 42±14 years). Methods Patients with aggressive corneal ... Cited by 26 - Related articles - BL Direct - All 2 versions
LFM Barros, R Belfort-Jr - Anais da Academia Brasileira de Ciências, 2007 - SciELO Brasil The purpose of this study was to evaluate the effects of the use of the
subconjunctival injection of bevacizumab (Avastin ® ) on angiogenesis in the
rat cornea. Corneas of 20 Wistar male rats were cauterized with silver ... Cited by 24 - Related articles - Cached - BL Direct - All 5 versions
MD Hamid Hosseini, MD Mahmood Nejabat, MD … - Clinical & Experimental Ophthalmology - interscience.wiley.com Methods: Chemical cauterization of the cornea was performed by touching central
cornea with a 5-mm-diameter NaOH-soaked cotton applicator for 10 s in 20 eyes of
20 White New Zealand rabbits. The rabbits were then divided randomly into ... Cited by 23 - Related articles - BL Direct - All 3 versions
- ►ibuprofendrama.nl [PDF] HS Uy, PS Chan, RE Ang - Cornea, 2008 - journals.lww.com Methods: This was a retrospective, interventional case report. Three eyes of 2
patients were examined. Bevacizumab (25 mg/mL) eyedrops were applied 4 times
daily for a period of 3 months. Main outcome measures were improvement of ... Cited by 27 - Related articles - BL Direct - All 4 versions
I Bahar, I Kaiserman, P McAllum, D Rootman, … - Current Eye Research, 2008 - informahealthcare.com Purpose: We report on the use of subconjunctival bevacizumab on corneal vessel
density in recurrent pterygia.Methods: The charts of 5 patients with recurrent
pterygium, who received subconjunctival injections of bevacizumab (2.5 ... Cited by 25 - Related articles - BL Direct - All 4 versions
E Yoeruek, F Ziemssen, S Henke-Fahle, O Tatar … - Acta Ophthalmologica, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 21 - Related articles - BL Direct - All 2 versions
… , PG Theodossiadis, VS Liarakos, A Rouvas, … - American Journal of Ophthalmology, 2008 - Elsevier Twelve New Zealand white rabbits were involved, divided equally into four
groups. Only one eye per rabbit was used. Topical instillation of 10 μl 5% NaOH
solution was used, under general anesthesia, to induce corneal ... Cited by 18 - Related articles - All 18 versions
- ►duanessolution.com T Kim, SW Kim, S Kim, T Kim, EK Kim - Cornea, 2008 - journals.lww.com From the *Corneal Dystrophy Research Institute, Department of Ophthalmology,
Yonsei University College of Medicine, Seoul, Korea; †BK21 Project Team of
Nanobiomaterials for Cell-based Implants, Yonsei University, Seoul, Korea; ... Cited by 18 - Related articles - BL Direct - All 5 versions
